Nonalcoholic fatty liver disease — especially its necroinflammatory variant, nonalcoholic steatohepatitis — not only is a marker of cardiovascular disease but also may be involved in its pathogenesis. This might occur through the systemic release of proatherogenic mediators from the steatotic or inflamed liver as well as through the contribution of nonalcoholic fatty liver disease itself to insulin resistance and atherogenic dyslipidemia...
And more.
No comments:
Post a Comment